139 related articles for article (PubMed ID: 35735582)
21. Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.
Sotelo MJ; Sastre J; Maestro ML; Veganzones S; Viéitez JM; Alonso V; Grávalos C; Escudero P; Vera R; Aranda E; García-Alfonso P; Gallego-Plazas J; Lopez C; Pericay C; Arrivi A; Vicente P; Ballesteros P; Elez E; López-Ladrón A; Díaz-Rubio E
Ann Oncol; 2015 Mar; 26(3):535-41. PubMed ID: 25515656
[TBL] [Abstract][Full Text] [Related]
22. Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery.
Huang M; He J; Lai W; Liu L; Xu H; Zeng Y; Lan Q; Lin X; Chu Z
BMC Gastroenterol; 2022 Feb; 22(1):87. PubMed ID: 35227194
[TBL] [Abstract][Full Text] [Related]
23. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
[TBL] [Abstract][Full Text] [Related]
24. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
26. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
27. Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
Anticancer Res; 2020 Mar; 40(3):1651-1659. PubMed ID: 32132070
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
[TBL] [Abstract][Full Text] [Related]
29. Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/ MMP9 signaling.
Xiao B; Chen D; Luo S; Hao W; Jing F; Liu T; Wang S; Geng Y; Li L; Xu W; Zhang Y; Liao X; Zuo D; Wu Y; Li M; Ma Q
Oncotarget; 2016 Aug; 7(31):50057-50073. PubMed ID: 27367023
[TBL] [Abstract][Full Text] [Related]
30. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
[TBL] [Abstract][Full Text] [Related]
31. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.
Svoboda M; Slyskova J; Schneiderova M; Makovicky P; Bielik L; Levy M; Lipska L; Hemmelova B; Kala Z; Protivankova M; Vycital O; Liska V; Schwarzova L; Vodickova L; Vodicka P
Carcinogenesis; 2014 Jul; 35(7):1510-5. PubMed ID: 24583926
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
[TBL] [Abstract][Full Text] [Related]
33. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
34. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
35. Impact of sidedness of colorectal cancer on tumor immunity.
Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
[TBL] [Abstract][Full Text] [Related]
36. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
37. Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.
Wang YP; Song GH; Chen J; Xiao C; Li C; Zhong L; Sun X; Wang ZW; Deng GL; Yu FD; Xue YM; Tang HM; Peng ZH; Wang XL
Tumour Biol; 2016 Mar; 37(3):3247-55. PubMed ID: 26433389
[TBL] [Abstract][Full Text] [Related]
38. [Predictive value of preoperative detection of CEA and CA199 for prognosis in patients with stage II-III colorectal cancer].
Chen L; Jiang B; Di J; Zhang C; Wang Z; Zhang N; Xing J; Cui M; Yang H; Yao Z; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Sep; 18(9):914-9. PubMed ID: 26404690
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract][Full Text] [Related]
40. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
